SOUTH WINDSOR, CT -- Gerber Scientific, Inc. (NYSE: GRB) today reported fiscal 2007 first quarter net income of $2.0 million, or $0.09 per diluted share, on revenue of $137.5 million, compared with a net loss of $1.1 million, or $0.05 per diluted share, on revenue of $128.8 million for the first quarter of fiscal 2006. The prior year first quarter net loss included a non-cash income tax charge of $2.3 million, or $0.10 per diluted share, which was attributable to the reversal of a deferred tax asset associated with a tax legislation change in the United Kingdom. Foreign currency translation had the effect of increasing revenue by approximately $2.6 million in the first quarter of fiscal 2007 compared with the first quarter of fiscal 2006.

Marc T. Giles, President and Chief Executive Officer, said: "We had a strong start to our fiscal year achieving both revenue and operating profit objectives. We are pleased with our year-over-year revenue growth of nearly 7 percent, which was driven by new products sales and our resurgence in China.

"Our operating income of $4.4 million reflects an increase of 28 percent over the comparable quarter in the prior year. During the quarter, we used $10.1 million of cash from operations less capital expenditures, primarily to fund higher inventories and other working capital requirements."

For additional information please see our Quarterly Report on Form 10-Q for the fiscal quarter ended July 31, 2006, which will be filed with the Securities and Exchange Commission.

Gerber Scientific, Inc. (http://www.gerberscientific.com) is a leading international supplier of sophisticated automated manufacturing systems for the sign making and specialty graphics, apparel and flexible materials and ophthalmic lens processing industries. Headquartered in South Windsor, Connecticut, the Company operates through four businesses: Gerber Scientific Products, Spandex Ltd., Gerber Technology and Gerber Coburn.

Statements contained in this news release regarding the Company's expected financial condition, results of operations, cash flows and product launches are forward-looking statements that involve risks and uncertainties. For information identifying other important economic, political, regulatory, legal, technological, competitive and other uncertainties, readers are referred to the Company’s filings with the Securities and Exchange Commission, including but not limited to, the information included in Gerber Scientific’s Annual Report on Form 10-K for the fiscal year ended April 30, 2006 under the headings "Business," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations – Cautionary Note Concerning Factors That May Influence Future Results," as well as information included in subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K, which outline certain important risks regarding the Company's forward-looking statements. These risks include, but are not limited to, delays in the Company's new product development and commercialization, intense competition in markets for each of the Company's operating segments, rapid technological advances, availability and cost of raw materials, apparel trade quotas, volatility in foreign currency exchange rates and fluctuations in interest rates. The Company expressly disclaims any obligation to update any of these forward-looking statements, except as required by law. Actual future results or events may differ materially from these forward-looking statements.